Skip to content
Use caution Drug recall · FDA · Published August 17, 2015

Apotex Recalls Cevimeline Capsules Due to Stability Issues

Apotex recalls specific lots of Cevimeline Hydrochloride Capsules because they may not meet assay specifications. Check your bottle's lot number and expiration date.

🇺🇸 FDA recall #D-1814-2015DrugApotex ›
Take action

Contact the company

Recalling firmApotex Inc.150 Signet Drive · Toronto, Canada
✎ GovInfoNow plain-language explainer

What happened, in plain English

Apotex Inc. is recalling Cevimeline Hydrochloride Capsules, 30 mg, in both 100-count and 500-count bottles. The recall was initiated because the product failed stability specifications and may not meet the required limit for the assay test. This means the medication might not contain the correct amount of active ingredient. Read more at govinfonow.com/recall/43847-apotex-inc-recalls-cevimeline-hydrochloride-capsules-30-mg-a-100.

Source Summary by GovInfoNow · govinfonow.com/recall/43847-apotex-inc-recalls-cevimeline-hydrochloride-capsules-30-mg-a-100 · Updated October 12, 2026 · FDA enforcement record: FDA #D-1814-2015

Cite this page

“Apotex Recalls Cevimeline Capsules Due to Stability Issues.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/43847-apotex-inc-recalls-cevimeline-hydrochloride-capsules-30-mg-a-100. Based on FDA recall #D-1814-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1814-2015%22&limit=1).

Why it’s dangerous

The capsules failed stability specifications, which means the chemical composition may have degraded over time. Consequently, the product may not meet the specification limit for the assay test, potentially resulting in incorrect dosage levels that could affect treatment efficacy.

Who’s affected

Patients who have been prescribed Cevimeline Hydrochloride Capsules by a healthcare provider are affected. Individuals who purchased these specific bottles from pharmacies nationwide or in Puerto Rico before August 17, 2015, may own the recalled product.

How to tell if you have this one

Check your medication bottle for the brand Apotex and the NDC numbers 60505-3145-1 (100 count) or 60505-3145-5 (500 count). Verify if the lot number is KP9749, KT3501, KP4524, KV8264, KX8713, KX8714, KX8715, KP4525, KP9750, or KX8716. Confirm the expiration date is between September 2015 and April 2016.

  • Brand
    Apotex
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Contact Your Pharmacist

    Reach out to your pharmacy or healthcare provider to determine if you have any of the recalled lots and to discuss alternative treatment options.

  2. Do Not Dispose Without Guidance

    The recall record does not specify a return, discard, or refund procedure, so follow your pharmacist's instructions for proper disposal.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 6.8 years after the firm started it.

1. Firm started the recall: Aug 17, 201512. FDA classified it Class II: Sep 15, 201523. Published in FDA’s Enforcement Report: Sep 23, 201534. FDA terminated the recall: Jun 15, 2022420152022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

How can I identify if my bottle is part of this recall?

Look for NDC 60505-3145-1 (100 count) or NDC 60505-3145-5 (500 count), manufactured by Apotex Research Pvt., Ltd. in Bangalore, India, and distributed by Apotex Corp.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1814-2015 (August 17, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1814-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA